| Description |
1 online resource (xvi, 292 pages) |
| Contents |
What are medicines and why are they special? -- Clinical trials -- Licensing -- Pharmacovigilance and liability for dangerous drugs -- Marketing -- Funding and access to medicines in the UK -- Funding and access to medicines : a global problem -- The future of medicines I : pharmacogenetics -- The future of medicines II : enhancement |
| Summary |
The principal purpose of this book is to tell the story of a medicine''s journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine''s regulation are examined separately: first, pharmacogenetics, or |
| Bibliography |
Includes bibliographical references (pages 267-292) |
| Notes |
Print version record |
| Subject |
Drugs -- Law and legislation -- Great Britain
|
|
Pharmacy -- Law and legislation -- Great Britain
|
|
Legislation, Drug -- economics
|
|
Clinical Trials as Topic
|
|
Drug Industry -- legislation & jurisprudence
|
|
LAW -- Administrative Law & Regulatory Practice.
|
|
Drugs -- Law and legislation
|
|
Pharmacy -- Law and legislation
|
|
United Kingdom |
|
Great Britain
|
| Form |
Electronic book
|
| ISBN |
9781847319081 |
|
1847319084 |
|
9781474200776 |
|
147420077X |
|
9781847319098 |
|
1847319092 |
|
